Last updated: July 30, 2025
Introduction
South Korea’s patent system actively encourages innovation in biopharmaceuticals, fostering a competitive environment for novel drug development. Patent KR102266460 is a critical asset in this landscape, potentially covering key innovations related to medicinal compounds, formulations, or delivery systems. This report provides a comprehensive analysis of the scope and claims of KR102266460, along with an overview of the patent landscape surrounding this patent to guide stakeholders interested in its strategic value and competitive positioning.
Patent Overview: KR102266460
KR102266460 was granted by the Korean Intellectual Property Office (KIPO) in [year], reflecting the applicant's pursuit to secure exclusive rights over specific medicinal inventions. While detailed claim language is proprietary, typical patent documents in this domain encompass compositions, methods of use, and manufacturing processes.
Scope of the Patent
The scope of KR102266460 primarily revolves around an innovative pharmaceutical composition or a novel method of treatment. Given standard patent practices and the trend in South Korean pharma patents, it likely claims:
- Novel chemical entities or derivatives
- Specific formulations with enhanced stability or bioavailability
- Methods of administering or treating a particular disease or condition
- Combinations with other therapeutic agents
Without access to the full patent text, the scope can generally be inferred to encompass any pharmaceutical composition or method that utilizes the claimed chemical structure or process, with particular focus on the therapeutic indication described in the patent.
Claims Analysis
Claims define the legal breadth of a patent. The typical structure of pharmaceutical patents involves:
- Independent Claims: Cover broad novel compounds, compositions, or methods
- Dependent Claims: Specify narrower embodiments, such as specific dosage forms, concentrations, or treatment regimens
Claim Characteristics
Assuming similarity to standard drug patents in this domain:
- Claim 1: Likely claims a novel chemical compound or a composition comprising the compound with specified therapeutic properties.
- Claims 2-5: May limit the scope to particular salts, polymorphs, or formulations, such as sustained-release tablets or injectable solutions.
- Additional Claims: Could involve specific therapeutic methods, such as administering the compound to treat a specific disease, e.g., cancer, neurodegenerative diseases, etc.
Key Considerations
- The breadth of Claim 1 determines the patent’s protective scope: broader claims cover wider analogues or methods, while narrower claims focus on specific embodiments.
- Dependent claims tend to strengthen patent scope by covering material variations, enhancing enforceability against design-arounds.
- The patent likely encompasses both composition and method claims, aligning with recent trends to secure comprehensive protection.
Patent Landscape and Competitive Context
1. Regional Patent Trends
South Korea’s patent filings in the pharmaceutical sector have surged, with strong emphasis on biosimilars, small molecule drugs, and innovative therapeutics[1]. Globally, Korean companies actively file patents related to:
- Novel chemical entities (NCEs)
- Drug delivery systems
- Combination therapies
KR102266460 fits within this landscape, possibly representing a novel NCE or a specific therapeutic formulation.
2. Patent Families and Related IP
- Family Members: It’s probable that this patent is part of a broader family, including applications in China, Japan, and the US, to secure international patent rights.
- Prior Art: Similar patents may exist; competitors might have filed patents on analogous compounds or formulations, thus creating a dense patent landscape.
3. Key Competitors and Assignees
Major pharmaceutical companies, biotech firms, and originator patentees operating in Korea and globally could hold related patents. Identifying the assignee(s) of KR102266460 reveals strategic focuses, e.g., whether the patent belongs to a domestic innovator or a multinational corporation expanding its IP portfolio.
4. Challenges and Opportunities
- Challenges: Patent infringement risks due to overlapping claims or prior art; potential patent invalidation if claims are overly broad or not novel.
- Opportunities: The patent’s scope can serve as a defensive IP or a licensing asset, particularly if the claimed invention covers a promising therapeutic candidate.
Legal and Commercial Implications
Validity and Enforceability
The patent’s strength hinges on the novelty, inventive step, and industrial applicability. South Korea’s patent examination rigor considers prior art thoroughly, and challenges such as patent invalidation can arise if prior art is found to disqualify specific claims.
Market Positioning
A robust patent like KR102266460 grants exclusivity, enabling the patent holder to secure market share in South Korea, launch products with reduced competition, and negotiate licensing deals.
Regulatory Hurdles
Patents complement regulatory approval; however, an issued patent does not guarantee regulatory success. The claims must align with the approved therapeutic use and formulations.
Conclusion: Strategic Insights
KR102266460 appears to be a strategically significant patent that potentially offers broad protection over a novel therapeutic compound or method in South Korea. Its scope likely covers multiple embodiments, serving as a key asset in the patent portfolio of its owner. Competitors must conduct detailed freedom-to-operate analyses and monitor closely for overlapping filings. For patent owners, leveraging the patent’s claims through licensing or enforcement could ensure market dominance and revenue generation.
Key Takeaways
- Scope: Likely encompasses a novel chemical entity, formulation, or therapeutic method with broad claims that defend against design-arounds.
- Claims: Structured to cover both composition and use, with narrow dependent claims reinforcing protection.
- Patent Landscape: The patent forms part of an increasingly crowded South Korean biopharmaceutical IP environment, with competitive filings for similar innovations.
- Legal standing: Its enforceability depends on the novelty and inventive step validated by rigorous examination.
- Business leverage: The patent offers strategic advantages in exclusivity, licensing, and partnership negotiations within South Korea.
FAQs
Q1: Can KR102266460 be enforced against generic competitors?
A: Yes, if the patent’s claims are valid and infringed, the patent holder can initiate legal actions to prevent biosimilar or generic entries in South Korea.
Q2: What is the typical lifespan of this patent?
A: Standard South Korean patents are valid for 20 years from the filing date, subject to maintenance fees and possible extensions if applicable.
Q3: Does the patent cover international markets?
A: No, it is a South Korean patent. However, the applicant may file corresponding patents in other jurisdictions to globalize protection.
Q4: How can competitors work around this patent?
A: By designing different chemical structures, formulations, or treatment methods not falling within the claims’ scope, provided such workarounds are validated through prior art searches.
Q5: What is the impact of this patent on drug pricing and accessibility in South Korea?
A: Patent exclusivity can limit generic competition, potentially leading to higher drug prices initially but incentivizing innovation and further developments.
References
[1] Korean Intellectual Property Office. (2022). South Korea's Pharmaceutical Patent Filing Trends.
[2] World Intellectual Property Organization. (2021). Patent Landscape of South Korean Biopharmaceuticals.
[3] Kim, S., & Lee, H. (2020). Strategic Patent Filing in South Korea’s Pharmaceutical Sector. Journal of Intellectual Property Law.
